Ginsenoside Rg3: Potential Molecular Targets and Therapeutic Indication in Metastatic Breast Cancer Nakhjavani, Maryam, Hardingham, JE, Palethorpe, HM, Tomita, Y, Smith, E, Price, TJ and Townsend, AR 2019, Ginsenoside Rg3: Potential Molecular Targets and Therapeutic Indication in Metastatic Breast Cancer, Medicines, vol. 6, no. 1, pp. 1-20, doi: 10.3390/medicines6010017. Attached Files Name Description MIMEType Size Downloads Title Ginsenoside Rg3: Potential Molecular Targets and Therapeutic Indication in Metastatic Breast Cancer Author(s) Nakhjavani, Maryam Hardingham, JE Palethorpe, HM Tomita, Y Smith, E Price, TJ Townsend, AR Journal name Medicines Volume number 6 Issue number 1 Article ID 17 Start page 1 End page 20 Total pages 20 Publisher MDPI AG Place of publication Basel, Switzerland Publication date 2019-01 ISSN 2305-6320 2305-6320 Keyword(s) angiogenesis AQP-1 breast cancer epimer Ginsenoside Rg3 Summary Breast cancer is still one of the most prevalent cancers and a leading cause of cancer death worldwide. The key challenge with cancer treatment is the choice of the best therapeutic agents with the least possible toxicities on the patient. Recently, attention has been drawn to herbal compounds, in particular ginsenosides, extracted from the root of the Ginseng plant. In various studies, significant anti-cancer properties of ginsenosides have been reported in different cancers. The mode of action of ginsenoside Rg3 (Rg3) in in vitro and in vivo breast cancer models and its value as an anti-cancer treatment for breast cancer will be reviewed Language eng DOI 10.3390/medicines6010017 HERDC Research category C1 Refereed article in a scholarly journal Free to Read? Yes Persistent URL http://hdl.handle.net/10536/DRO/DU:30159027 Document type: Journal Article Collections: Faculty of Health School of Medicine Open Access Collection Related Links Link Description Link to full-text (open access)   Connect to Elements publication management system Go to link with your DU access privileges     Unless expressly stated otherwise, the copyright for items in DRO is owned by the author, with all rights reserved. Every reasonable effort has been made to ensure that permission has been obtained for items included in DRO. If you believe that your rights have been infringed by this repository, please contact drosupport@deakin.edu.au. Versions Version Filter Type Mon, 22 Nov 2021, 09:37:03 EST Mon, 22 Nov 2021, 15:16:57 EST Mon, 22 Nov 2021, 15:23:24 EST Fri, 26 Nov 2021, 15:14:23 EST Thu, 20 Jan 2022, 10:45:32 EST Thu, 20 Jan 2022, 11:37:54 EST Thu, 20 Jan 2022, 11:42:40 EST Filtered Full Citation counts:   Cited 0 times in TR Web of Science Cited 0 times in Scopus Search Google Scholar Access Statistics: 43 Abstract Views, 0 File Downloads  -  Detailed Statistics Created: Mon, 22 Nov 2021, 09:37:03 EST